Hendertech, a phamaceutical comany, has developed a clot-dissolving drug called BSB that will halt a heart attach in progress. BSB saves lives, and reduces damage to the heart itself. It is priced at $1,200 per dose. What pricing approach does Hendertech appear to be using? Is demand for this drug likely to be elastic? Why?